MAHMUD, A. A.; ANU, U. H.; FOYSAL, K. A.; HASAN, M. .; SAZIB, S. M.; RAGIB, A. A.; TAHER, A. B.; HOSSAIN, M. S. .; ISLAM, M. S.; HOSSAIN, M. S. .; EMRAN, T. B. Elevated serum malondialdehyde (MDA), insulin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and thyroid-stimulating hormone (TSH), and reduced antioxidant vitamins in polycystic ovarian syndrome patients . Narra J, [S. l.], v. 2, n. 1, 2022. DOI: 10.52225/narra.v2i1.56. Disponível em: https://www.narraj.org/main/article/view/56. Acesso em: 17 sep. 2025.